News

Univfy picks up $6 mln Series A

Univfy, a predictive machine learning and fintech platform that provides fertility patients with personalized probabilities of IVF success, has secured $6 million in Series A funding. Rethink Impact led the round.

Rani Therapeutics hauls in $53 mln

Rani Therapeutics, a developer of a pill designed to replace injectable drug delivery for patients suffering from chronic diseases, has raised $53 million in funding. The investors included GeneScience Pharmaceuticals, Bossa Ventures, Cathay Venture Inc, GV, Alphabet Inc's investment arm, Novartis, AstraZeneca, Ping An Ventures and Virtus Ventures.

TribalScale launches $100 mln venture-studio program

TribalScale, a creator of digital product strategy, design, and development, has launched TribalScale Venture Studios, a $100 million, five-year program that will connect entrepreneurs with Fortune 500 companies to launch industry-specific startups. The program will focus on four sectors: financial services, automotive, media and travel and hospitality. TribalScale has offices in Toronto, New York City, San Francisco, Dubai and Irvine, California.

Notation Capital launches its second fund with a focus on transparency

TrueBridge Capital Partners raises $450 mln for fifth venture fund-of-funds

TrueBridge Capital Partners has closed its fifth venture capital fund-of-funds at a hard cap of $450 million, beating its $375 million target. TrueBridge Fund V's limited partners include foundations and endowments, corporate and public pension funds, family offices and high-net-worth individuals.

Enerkem’s C$280 mln round is Canada’s biggest cleantech VC deal ever

TLV Partners raises $152.3 mln for second venture fund

TLV Partners has raised $152.3 million for a second venture capital fund, according to a filing with the SEC.

Can an ICO replace early-stage VC? 500 Startups alums hope so

Edmond De Rothschild Investment Partners wraps up biotech and medical device fund at $430 mln

Edmond De Rothschild Investment Partners has closed its fifth European biotech and medical device venture fund at 345 million euros ($430 million). The fund beat its initial target of 250 million euros.

Zenflow picks up $31.4 mln Series A

South San Francisco-based Zenflow Inc, a medical device company, has secured $31.4 million in Series A funding. Invus Opportunities, F-Prime Capital Partners and Medical Technology Venture Partners led the round.